These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34654435)

  • 1. A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1).
    Zhang Z; Zhang J; Tian J; Li H
    J Nanobiotechnology; 2021 Oct; 19(1):323. PubMed ID: 34654435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
    Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
    Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinobufagin-Loaded and Folic Acid-Modified Polydopamine Nanomedicine Combined With Photothermal Therapy for the Treatment of Lung Cancer.
    Li J; Zhang Z; Deng H; Zheng Z
    Front Chem; 2021; 9():637754. PubMed ID: 33855009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells.
    Yang D; Li L; Liu H; Wu L; Luo Z; Li H; Zheng S; Gao H; Chu Y; Sun Y; Liu J; Jia L
    Cell Death Differ; 2013 Feb; 20(2):235-47. PubMed ID: 22935614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
    Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
    Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecin-Loaded and Manganese Dioxide-Coated Polydopamine Nanomedicine Used for Magnetic Resonance Imaging Diagnosis and Chemo-Photothermal Therapy for Lung Cancer.
    Su M; Chen Y; Jia L; Zhang Z
    Int J Nanomedicine; 2022; 17():6687-6705. PubMed ID: 36597434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
    Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
    Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics.
    Zhu M; Shi Y; Shan Y; Guo J; Song X; Wu Y; Wu M; Lu Y; Chen W; Xu X; Tang L
    J Nanobiotechnology; 2021 Nov; 19(1):387. PubMed ID: 34819084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and DNAzyme using ZnO@polydopamine core-shell nanocomposites for chemo/gene/photothermal therapy.
    Liu M; Peng Y; Nie Y; Liu P; Hu S; Ding J; Zhou W
    Acta Biomater; 2020 Jul; 110():242-253. PubMed ID: 32438113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.
    You YH; Lin YF; Nirosha B; Chang HT; Huang YF
    Nanotheranostics; 2019; 3(3):266-283. PubMed ID: 31263658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
    Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
    Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
    Liu B; Cao W; Qiao G; Yao S; Pan S; Wang L; Yue C; Ma L; Liu Y; Cui D
    Acta Biomater; 2019 Nov; 99():307-319. PubMed ID: 31513911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted accumulation of oxygen-irrelevant free radicals for enhanced synergistic low-temperature photothermal and thermodynamic therapy.
    Hu H; Deng X; Song Q; Yang W; Zhang Y; Liu W; Wang S; Liang Z; Xing X; Zhu J; Zhang J; Shao Z; Wang B; Zhang Y
    J Nanobiotechnology; 2021 Nov; 19(1):390. PubMed ID: 34823543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and
    Shao L; Li Y; Huang F; Wang X; Lu J; Jia F; Pan Z; Cui X; Ge G; Deng X; Wu Y
    Theranostics; 2020; 10(16):7273-7286. PubMed ID: 32641992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Multifunctional Stimuli-Responsive Nanoparticles for Synergetic Chemo-Photothermal Therapy of Tumors.
    Pu XQ; Ju XJ; Zhang L; Cai QW; Liu YQ; Peng HY; Xie R; Wang W; Liu Z; Chu LY
    ACS Appl Mater Interfaces; 2021 Jun; 13(24):28802-28817. PubMed ID: 34109788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
    Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
    Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
    Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Synthesis of New PEGylated Polydopamine-Based Nanoconstructs Bearing ROS-Responsive Linkers and a Photosensitizer for Bimodal Photothermal and Photodynamic Therapies against Cancer.
    Zmerli I; Ibrahim N; Cressey P; Denis S; Makky A
    Mol Pharm; 2021 Sep; 18(9):3623-3637. PubMed ID: 34431682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydopamine Coated PB-MnO
    Odda AH; Li H; Kumar N; Ullah N; Khan MI; Wang G; Liang K; Liu T; Pan YY; Xu AW
    Bioconjug Chem; 2020 May; 31(5):1474-1485. PubMed ID: 32286806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.